Cargando…

How to Prevent Loss of Muscle Mass and Strength among Older People in Neuro-Rehabilitation?

Stroke is the second leading cause of death worldwide but also of disability. Stroke induces certain alterations of muscle metabolism associated with gross muscle atrophy and a decrease in muscle function, leading to sarcopenia. The vast majority of stroke cases occur in adults over 65 years of age,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lathuilière, Aurélien, Mareschal, Julie, Graf, Christophe E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521136/
https://www.ncbi.nlm.nih.gov/pubmed/31010176
http://dx.doi.org/10.3390/nu11040881
_version_ 1783418887345274880
author Lathuilière, Aurélien
Mareschal, Julie
Graf, Christophe E.
author_facet Lathuilière, Aurélien
Mareschal, Julie
Graf, Christophe E.
author_sort Lathuilière, Aurélien
collection PubMed
description Stroke is the second leading cause of death worldwide but also of disability. Stroke induces certain alterations of muscle metabolism associated with gross muscle atrophy and a decrease in muscle function, leading to sarcopenia. The vast majority of stroke cases occur in adults over 65 years of age, and the prevalence is expected to massively increase in the coming years in this population. Sarcopenia is associated with higher mortality and functional decline. Therefore, the identification of interventions that prevent muscle alterations after stroke is of great interest. The purpose of this review is to carry out a systematic literature review to identify evidence for nutritional and pharmacological interventions, which may prevent loss of muscle mass in the elderly after stroke. The search was performed on Medline in December 2018. Randomized controlled studies, observational studies and case reports conducted in the last 20 years on post-stroke patients aged 65 or older were included. In total, 684 studies were screened, and eight randomized control trials and two cohort studies were finally included and examined. This review reveals that interventions such as amino acid supplementation or anabolic steroid administration are efficient to prevent muscle mass. Little evidence is reported on nutritional aspects specifically in sarcopenia prevention after stroke. It pinpoints the need for future studies in this particular population.
format Online
Article
Text
id pubmed-6521136
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65211362019-05-31 How to Prevent Loss of Muscle Mass and Strength among Older People in Neuro-Rehabilitation? Lathuilière, Aurélien Mareschal, Julie Graf, Christophe E. Nutrients Communication Stroke is the second leading cause of death worldwide but also of disability. Stroke induces certain alterations of muscle metabolism associated with gross muscle atrophy and a decrease in muscle function, leading to sarcopenia. The vast majority of stroke cases occur in adults over 65 years of age, and the prevalence is expected to massively increase in the coming years in this population. Sarcopenia is associated with higher mortality and functional decline. Therefore, the identification of interventions that prevent muscle alterations after stroke is of great interest. The purpose of this review is to carry out a systematic literature review to identify evidence for nutritional and pharmacological interventions, which may prevent loss of muscle mass in the elderly after stroke. The search was performed on Medline in December 2018. Randomized controlled studies, observational studies and case reports conducted in the last 20 years on post-stroke patients aged 65 or older were included. In total, 684 studies were screened, and eight randomized control trials and two cohort studies were finally included and examined. This review reveals that interventions such as amino acid supplementation or anabolic steroid administration are efficient to prevent muscle mass. Little evidence is reported on nutritional aspects specifically in sarcopenia prevention after stroke. It pinpoints the need for future studies in this particular population. MDPI 2019-04-19 /pmc/articles/PMC6521136/ /pubmed/31010176 http://dx.doi.org/10.3390/nu11040881 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Lathuilière, Aurélien
Mareschal, Julie
Graf, Christophe E.
How to Prevent Loss of Muscle Mass and Strength among Older People in Neuro-Rehabilitation?
title How to Prevent Loss of Muscle Mass and Strength among Older People in Neuro-Rehabilitation?
title_full How to Prevent Loss of Muscle Mass and Strength among Older People in Neuro-Rehabilitation?
title_fullStr How to Prevent Loss of Muscle Mass and Strength among Older People in Neuro-Rehabilitation?
title_full_unstemmed How to Prevent Loss of Muscle Mass and Strength among Older People in Neuro-Rehabilitation?
title_short How to Prevent Loss of Muscle Mass and Strength among Older People in Neuro-Rehabilitation?
title_sort how to prevent loss of muscle mass and strength among older people in neuro-rehabilitation?
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521136/
https://www.ncbi.nlm.nih.gov/pubmed/31010176
http://dx.doi.org/10.3390/nu11040881
work_keys_str_mv AT lathuiliereaurelien howtopreventlossofmusclemassandstrengthamongolderpeopleinneurorehabilitation
AT mareschaljulie howtopreventlossofmusclemassandstrengthamongolderpeopleinneurorehabilitation
AT grafchristophee howtopreventlossofmusclemassandstrengthamongolderpeopleinneurorehabilitation